XOVOLTIB 50MG DESCRIPTION This is a Phase 2 trial examine the performance of a targeted cancer drug known as Xovoltib 50mg . Xovoltib 50mg tablets prohibits the EGFR protein, which is accepting to be included in driving the growth of chordoma tumors. This study is plan specifically for chordoma patients 18 years or older with recurrent or metastatic tumors. Xovoltib 50mg which is used as prescription drugs under the guidance of oncologist physician. INDICATION Xovoltib 50mg tablets is used for the first-line treatment for patients with metastatic non-small cell lung cancer(NSCLC) MECHANISM OF ACTION Afatinib mechanism by preventing the activity of a group of proteins knowns as epidermal growth factor receptors (EGFR). Epidermal growth factor receptor is a protein which is included in the growth and spread of cancer cells; Afatinib works by inhibiting the action of this protein. Afatinib should not be taken by people who having EGFR-negative tumors. PRODUCT DETAILS ...